It is time to separate people's real needs from the arbitrary assessments of poverty that have guided Indian governments India's poverty line has always been a matter of huge debate, but it was a discussion mostly confined to economists and policymakers. But the matter has now gone public, following a row about an affidavit from the planning commission to the supreme court of India, in which the official poverty line was...

Six years of RTI’s existence has empowered the Indian citizen as a  proactive partner in governance like never before since Independence. But the government has not been able to digest it, ever since its implementation. Instead of trying to dilute or scuttle the Act, it’s time the government abides by Section (4) norms of ‘suo motu’ disclosure Apart from Prime Minister Manmohan Singh, whose innocence and ‘clean image’ stands exposed thanks...

-The Hindu   “Allowing oil firms to control market will hurt economy”   De-regulation by which the three public sector oil companies are empowered to set the price of petrol and other petroleum products has been challenged in a public interest litigation petition in the Supreme Court. The All India Youth Federation (AIYF), represented by its general secretary P. Sandoshkumar, said there was no rationale behind replacing the Administered Pricing Mechanism (APM) with the Import...

-PTI Even as a controversy rages over the Rs. 32 per capita per day poverty line, Planning Commission Deputy Chairman Montek Singh Ahluwalia has said “it is not all that ridiculous” in Indian conditions. “The fact is that Rs. 4,824 per month for a family [of five] to define poverty is not comfortable but it is not all that ridiculous in Indian conditions,” Mr. Ahluwalia said in a letter to Attorney-General Goolam...

Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...